MedX Health Corp
MDX.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -39.48% | -33.74% | 2.03% | -12.81% | 11.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -39.48% | -33.74% | 2.03% | -12.81% | 11.52% |
| Cost of Revenue | -18.10% | -25.24% | 21.71% | -1.87% | 17.09% |
| Gross Profit | -60.19% | -43.47% | -18.52% | -24.92% | 6.57% |
| SG&A Expenses | -30.83% | -18.61% | -21.47% | -21.18% | -17.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.97% | -17.50% | -17.14% | -23.30% | -16.61% |
| Operating Income | 23.55% | 14.76% | 19.73% | 24.68% | 20.20% |
| Income Before Tax | 41.78% | 26.98% | 18.27% | 13.84% | 3.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 41.78% | 26.98% | 18.27% | 13.84% | 3.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.78% | 26.98% | 18.27% | 13.84% | 3.56% |
| EBIT | 23.55% | 14.76% | 19.73% | 24.68% | 20.20% |
| EBITDA | 24.07% | 14.53% | 19.60% | 24.90% | 20.04% |
| EPS Basic | 58.33% | 41.04% | 27.23% | 17.13% | 4.00% |
| Normalized Basic EPS | 49.63% | 31.82% | 18.05% | 8.15% | 4.26% |
| EPS Diluted | 58.33% | 41.04% | 27.23% | 17.13% | 4.00% |
| Normalized Diluted EPS | 49.63% | 31.82% | 18.05% | 8.15% | 4.26% |
| Average Basic Shares Outstanding | 38.82% | 28.56% | 17.69% | 7.05% | 0.69% |
| Average Diluted Shares Outstanding | 38.82% | 28.56% | 17.69% | 7.05% | 0.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
